

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of T cell chemotaxis (GO:0010819) | 7.08095776 |
| 2 | positive regulation of T cell chemotaxis (GO:0010820) | 7.08095776 |
| 3 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.46630676 |
| 4 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 6.36445512 |
| 5 | Golgi to endosome transport (GO:0006895) | 5.61434709 |
| 6 | cellular response to interferon-beta (GO:0035458) | 5.52921842 |
| 7 | negative regulation of fibroblast apoptotic process (GO:2000270) | 5.22481461 |
| 8 | positive regulation of T cell migration (GO:2000406) | 4.93263472 |
| 9 | platelet dense granule organization (GO:0060155) | 4.91676269 |
| 10 | regulation of fibroblast apoptotic process (GO:2000269) | 4.91395158 |
| 11 | nuclear pore organization (GO:0006999) | 4.59477965 |
| 12 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.57007923 |
| 13 | mitotic cell cycle arrest (GO:0071850) | 4.51503629 |
| 14 | vesicle fusion (GO:0006906) | 4.49120139 |
| 15 | response to interferon-beta (GO:0035456) | 4.31421093 |
| 16 | mitotic metaphase plate congression (GO:0007080) | 4.25178205 |
| 17 | negative regulation of phagocytosis (GO:0050765) | 4.24749954 |
| 18 | regulation of T cell migration (GO:2000404) | 4.23805169 |
| 19 | positive regulation of lymphocyte migration (GO:2000403) | 4.22165072 |
| 20 | protein deneddylation (GO:0000338) | 4.06739977 |
| 21 | gonadal mesoderm development (GO:0007506) | 4.02301497 |
| 22 | signal peptide processing (GO:0006465) | 4.00391343 |
| 23 | protein localization to kinetochore (GO:0034501) | 3.92286310 |
| 24 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.85316449 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.85316449 |
| 26 | protein localization to chromosome, centromeric region (GO:0071459) | 3.83845677 |
| 27 | mitotic sister chromatid cohesion (GO:0007064) | 3.83334459 |
| 28 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.77375407 |
| 29 | metaphase plate congression (GO:0051310) | 3.74664892 |
| 30 | establishment of chromosome localization (GO:0051303) | 3.73918031 |
| 31 | IMP metabolic process (GO:0046040) | 3.72172073 |
| 32 | N-terminal protein amino acid acetylation (GO:0006474) | 3.71085325 |
| 33 | IMP biosynthetic process (GO:0006188) | 3.70211910 |
| 34 | mitochondrion distribution (GO:0048311) | 3.65876147 |
| 35 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.64003860 |
| 36 | CENP-A containing nucleosome assembly (GO:0034080) | 3.63954004 |
| 37 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.59941984 |
| 38 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.57963909 |
| 39 | chromatin remodeling at centromere (GO:0031055) | 3.52740688 |
| 40 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.48977455 |
| 41 | negative regulation of execution phase of apoptosis (GO:1900118) | 3.42131755 |
| 42 | definitive hemopoiesis (GO:0060216) | 3.41715026 |
| 43 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.41066283 |
| 44 | mitotic spindle checkpoint (GO:0071174) | 3.40613434 |
| 45 | regulation of cellular respiration (GO:0043457) | 3.38711760 |
| 46 | spindle checkpoint (GO:0031577) | 3.36985433 |
| 47 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.36855729 |
| 48 | negative regulation of sister chromatid segregation (GO:0033046) | 3.36855729 |
| 49 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.36855729 |
| 50 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.36855729 |
| 51 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.36855729 |
| 52 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.35087486 |
| 53 | superoxide anion generation (GO:0042554) | 3.33005352 |
| 54 | negative regulation of activin receptor signaling pathway (GO:0032926) | 3.32555292 |
| 55 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.32521491 |
| 56 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.32521491 |
| 57 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.30678889 |
| 58 | sequestering of actin monomers (GO:0042989) | 3.30365600 |
| 59 | positive regulation of mitochondrial fission (GO:0090141) | 3.30168509 |
| 60 | regulation of lymphocyte migration (GO:2000401) | 3.29153258 |
| 61 | cytochrome complex assembly (GO:0017004) | 3.26744614 |
| 62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26521171 |
| 63 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.25818454 |
| 64 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.25818454 |
| 65 | regulation of sister chromatid segregation (GO:0033045) | 3.25818454 |
| 66 | spermatid nucleus differentiation (GO:0007289) | 3.25523533 |
| 67 | negative regulation of chromosome segregation (GO:0051985) | 3.24887466 |
| 68 | formation of translation preinitiation complex (GO:0001731) | 3.24130459 |
| 69 | mitotic spindle assembly checkpoint (GO:0007094) | 3.22996645 |
| 70 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.22968722 |
| 71 | spindle assembly checkpoint (GO:0071173) | 3.22149205 |
| 72 | ribosome assembly (GO:0042255) | 3.15720395 |
| 73 | DNA double-strand break processing (GO:0000729) | 3.14120620 |
| 74 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.06586325 |
| 75 | DNA replication-independent nucleosome organization (GO:0034724) | 3.06586325 |
| 76 | autophagic vacuole fusion (GO:0000046) | 3.06087087 |
| 77 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.05356989 |
| 78 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.05356989 |
| 79 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.05356989 |
| 80 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.03612100 |
| 81 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.03581364 |
| 82 | purine nucleobase biosynthetic process (GO:0009113) | 3.02076962 |
| 83 | AMP metabolic process (GO:0046033) | 3.01290509 |
| 84 | response to increased oxygen levels (GO:0036296) | 3.00645316 |
| 85 | response to hyperoxia (GO:0055093) | 3.00645316 |
| 86 | histamine secretion (GO:0001821) | 3.00198809 |
| 87 | regulation of chromosome segregation (GO:0051983) | 2.99464040 |
| 88 | establishment of integrated proviral latency (GO:0075713) | 2.98768546 |
| 89 | transcription from RNA polymerase I promoter (GO:0006360) | 2.98564381 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.93768635 |
| 91 | regulation of germinal center formation (GO:0002634) | 2.92232449 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 2.90621237 |
| 93 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.89694306 |
| 94 | intracellular pH reduction (GO:0051452) | 2.89591842 |
| 95 | ether lipid metabolic process (GO:0046485) | 2.89317869 |
| 96 | positive regulation of chromosome segregation (GO:0051984) | 2.88471758 |
| 97 | purine nucleotide salvage (GO:0032261) | 2.87905348 |
| 98 | regulation of meiosis I (GO:0060631) | 2.87715431 |
| 99 | sister chromatid segregation (GO:0000819) | 2.86299734 |
| 100 | histone exchange (GO:0043486) | 2.85827123 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84341635 |
| 102 | proteasome assembly (GO:0043248) | 2.84341245 |
| 103 | T-helper cell differentiation (GO:0042093) | 2.84070554 |
| 104 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.84070554 |
| 105 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.83874314 |
| 106 | negative regulation of ligase activity (GO:0051352) | 2.83874314 |
| 107 | nuclear pore complex assembly (GO:0051292) | 2.83860648 |
| 108 | mitotic G2/M transition checkpoint (GO:0044818) | 2.83339313 |
| 109 | mitotic nuclear envelope disassembly (GO:0007077) | 2.83270105 |
| 110 | lactate metabolic process (GO:0006089) | 2.83230135 |
| 111 | protein neddylation (GO:0045116) | 2.79751682 |
| 112 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.79454419 |
| 113 | membrane budding (GO:0006900) | 2.79450230 |
| 114 | reactive oxygen species biosynthetic process (GO:1903409) | 2.77825042 |
| 115 | mitotic sister chromatid segregation (GO:0000070) | 2.77664368 |
| 116 | mitotic chromosome condensation (GO:0007076) | 2.77109790 |
| 117 | hepatocyte apoptotic process (GO:0097284) | 2.76794016 |
| 118 | cyclooxygenase pathway (GO:0019371) | 2.76562104 |
| 119 | non-recombinational repair (GO:0000726) | 2.75653894 |
| 120 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.75653894 |
| 121 | Notch receptor processing (GO:0007220) | 2.73586317 |
| 122 | synapsis (GO:0007129) | 2.73102338 |
| 123 | protein refolding (GO:0042026) | 2.72776766 |
| 124 | protein homotrimerization (GO:0070207) | 2.71169836 |
| 125 | protein localization to chromosome (GO:0034502) | 2.70488929 |
| 126 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.70344453 |
| 127 | purine-containing compound salvage (GO:0043101) | 2.70145229 |
| 128 | protein localization to microtubule (GO:0035372) | 2.69740735 |
| 129 | nuclear envelope disassembly (GO:0051081) | 2.69228265 |
| 130 | membrane disassembly (GO:0030397) | 2.69228265 |
| 131 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.68138185 |
| 132 | daunorubicin metabolic process (GO:0044597) | 2.67882543 |
| 133 | polyketide metabolic process (GO:0030638) | 2.67882543 |
| 134 | doxorubicin metabolic process (GO:0044598) | 2.67882543 |
| 135 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.67610793 |
| 136 | L-fucose metabolic process (GO:0042354) | 2.67054354 |
| 137 | L-fucose catabolic process (GO:0042355) | 2.67054354 |
| 138 | fucose catabolic process (GO:0019317) | 2.67054354 |
| 139 | negative regulation of proteasomal protein catabolic process (GO:1901799) | 2.66805419 |
| 140 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.66309051 |
| 141 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.65750712 |
| 142 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.65433751 |
| 143 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.65433751 |
| 144 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435) | 2.64856090 |
| 145 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.64725035 |
| 146 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.63569827 |
| 147 | endosome to pigment granule transport (GO:0043485) | 2.62923391 |
| 148 | endosome to melanosome transport (GO:0035646) | 2.62923391 |
| 149 | tricarboxylic acid cycle (GO:0006099) | 2.62812056 |
| 150 | termination of RNA polymerase I transcription (GO:0006363) | 2.61179168 |
| 151 | protein K11-linked ubiquitination (GO:0070979) | 2.61035779 |
| 152 | ribonucleoprotein complex disassembly (GO:0032988) | 2.60743078 |
| 153 | neutrophil activation involved in immune response (GO:0002283) | 2.60429914 |
| 154 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.60145814 |
| 155 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.58820757 |
| 156 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.58790575 |
| 157 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.58701213 |
| 158 | positive regulation of ligase activity (GO:0051351) | 2.58418415 |
| 159 | organelle disassembly (GO:1903008) | 2.57475617 |
| 160 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.57279544 |
| 161 | multi-organism transport (GO:0044766) | 2.57258596 |
| 162 | multi-organism localization (GO:1902579) | 2.57258596 |
| 163 | multi-organism intracellular transport (GO:1902583) | 2.57258596 |
| 164 | transport of virus (GO:0046794) | 2.57258596 |
| 165 | intracellular transport of virus (GO:0075733) | 2.57258596 |
| 166 | regulation of cofactor metabolic process (GO:0051193) | 2.56348178 |
| 167 | regulation of coenzyme metabolic process (GO:0051196) | 2.56348178 |
| 168 | oxidative phosphorylation (GO:0006119) | 2.56316766 |
| 169 | membrane protein ectodomain proteolysis (GO:0006509) | 2.54444160 |
| 170 | cullin deneddylation (GO:0010388) | 2.54092174 |
| 171 | negative regulation of DNA recombination (GO:0045910) | 2.53666500 |
| 172 | * cell cycle G1/S phase transition (GO:0044843) | 2.53466587 |
| 173 | * G1/S transition of mitotic cell cycle (GO:0000082) | 2.53466587 |
| 174 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.53032189 |
| 175 | metallo-sulfur cluster assembly (GO:0031163) | 2.52697881 |
| 176 | iron-sulfur cluster assembly (GO:0016226) | 2.52697881 |
| 177 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.52148177 |
| 178 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.50955717 |
| 179 | pore complex assembly (GO:0046931) | 2.49626666 |
| 180 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.49094387 |
| 181 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.48891206 |
| 182 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.48826103 |
| 183 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.48723645 |
| 184 | mitochondrial RNA metabolic process (GO:0000959) | 2.47121425 |
| 185 | positive regulation of vasculogenesis (GO:2001214) | 2.46127274 |
| 186 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.46105135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 5.33196494 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.46358588 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.36173713 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.34506036 |
| 5 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.13608477 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.12145049 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.04250994 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.75700002 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75408221 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.74160717 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.72707227 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.60410949 |
| 13 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.57019984 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.36657211 |
| 15 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.32823361 |
| 16 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32704442 |
| 17 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.30172918 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29085078 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.20174157 |
| 20 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.20091509 |
| 21 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.15984965 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.12227208 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.11136348 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.09421927 |
| 25 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07920541 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.06682199 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.04974708 |
| 28 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.04837517 |
| 29 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04507771 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.02753478 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.01057159 |
| 32 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.98694311 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.94804771 |
| 34 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.93563222 |
| 35 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.90136391 |
| 36 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.84379039 |
| 37 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.82826264 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81425509 |
| 39 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.80386750 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.78048583 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77052202 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.75560095 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.69886113 |
| 44 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.69801350 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.68507829 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66502736 |
| 47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.65855759 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65138786 |
| 49 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64532266 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.63831747 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62023030 |
| 52 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.61730149 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61218972 |
| 54 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.60651022 |
| 55 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60261973 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56292483 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53386266 |
| 58 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51030659 |
| 59 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48396239 |
| 60 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.47367113 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47251406 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46695296 |
| 63 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45088577 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.44477303 |
| 65 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43574620 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.41840969 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.40471029 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.37978803 |
| 69 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34742634 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33766420 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33766420 |
| 72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.33743706 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.31956672 |
| 74 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30802064 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30279173 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30193940 |
| 77 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.29607493 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29508220 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28956964 |
| 80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.28908563 |
| 81 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28560308 |
| 82 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26897378 |
| 83 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26651224 |
| 84 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.26539142 |
| 85 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26333331 |
| 86 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24266499 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23550142 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22050972 |
| 89 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21918036 |
| 90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.20733530 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.19613432 |
| 92 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.18520735 |
| 93 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18261995 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.16998476 |
| 95 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.16599695 |
| 96 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.16598332 |
| 97 | VDR_22108803_ChIP-Seq_LS180_Human | 1.16493183 |
| 98 | * SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16116953 |
| 99 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.14714491 |
| 100 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13344472 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12927580 |
| 102 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12860313 |
| 103 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12345796 |
| 104 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12345796 |
| 105 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12345796 |
| 106 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11104813 |
| 107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10928209 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08557990 |
| 109 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08051384 |
| 110 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07904047 |
| 111 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07788149 |
| 112 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07780181 |
| 113 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07324094 |
| 114 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07252730 |
| 115 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05379975 |
| 116 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04793145 |
| 117 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04519775 |
| 118 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02716658 |
| 119 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02279190 |
| 120 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01551864 |
| 121 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00482320 |
| 122 | MYB_26560356_Chip-Seq_TH2_Human | 0.99315641 |
| 123 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.98267692 |
| 124 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98089934 |
| 125 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.96447488 |
| 126 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96284907 |
| 127 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95967932 |
| 128 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95708722 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95652996 |
| 130 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.95549600 |
| 131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95349691 |
| 132 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94306559 |
| 133 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94162256 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92499477 |
| 135 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92022345 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91853190 |
| 137 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91083208 |
| 138 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.90652440 |
| 139 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.90471501 |
| 140 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89690613 |
| 141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89375562 |
| 142 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88465510 |
| 143 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87976980 |
| 144 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.87434091 |
| 145 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87154615 |
| 146 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.86309961 |
| 147 | MYB_26560356_Chip-Seq_TH1_Human | 0.85168077 |
| 148 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.84672281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 7.12010296 |
| 2 | MP0001545_abnormal_hematopoietic_system | 4.12579128 |
| 3 | MP0005397_hematopoietic_system_phenotyp | 4.12579128 |
| 4 | MP0002876_abnormal_thyroid_physiology | 3.67338272 |
| 5 | MP0009697_abnormal_copulation | 3.42688447 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.33117018 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.89543813 |
| 8 | MP0003693_abnormal_embryo_hatching | 2.86771839 |
| 9 | MP0008057_abnormal_DNA_replication | 2.84300877 |
| 10 | MP0003718_maternal_effect | 2.75503184 |
| 11 | MP0008058_abnormal_DNA_repair | 2.64524774 |
| 12 | MP0003221_abnormal_cardiomyocyte_apopto | 2.55953442 |
| 13 | MP0003724_increased_susceptibility_to | 2.53913339 |
| 14 | MP0001986_abnormal_taste_sensitivity | 2.44066954 |
| 15 | MP0003077_abnormal_cell_cycle | 2.41713354 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.31875263 |
| 17 | MP0004782_abnormal_surfactant_physiolog | 2.31834229 |
| 18 | MP0003111_abnormal_nucleus_morphology | 2.24333290 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.24091077 |
| 20 | MP0006054_spinal_hemorrhage | 2.20033908 |
| 21 | MP0003186_abnormal_redox_activity | 2.19892813 |
| 22 | MP0003941_abnormal_skin_development | 2.16357132 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.14674968 |
| 24 | MP0009785_altered_susceptibility_to | 2.13004480 |
| 25 | MP0001905_abnormal_dopamine_level | 2.10987595 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 2.10283392 |
| 27 | MP0000749_muscle_degeneration | 2.03732618 |
| 28 | MP0005671_abnormal_response_to | 2.02417593 |
| 29 | MP0008932_abnormal_embryonic_tissue | 2.00580021 |
| 30 | MP0000566_synostosis | 1.97399722 |
| 31 | MP0002009_preneoplasia | 1.88732378 |
| 32 | MP0002419_abnormal_innate_immunity | 1.85638093 |
| 33 | MP0003646_muscle_fatigue | 1.84800068 |
| 34 | MP0003806_abnormal_nucleotide_metabolis | 1.84196531 |
| 35 | MP0001730_embryonic_growth_arrest | 1.73785521 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.73132096 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.70618488 |
| 38 | MP0004145_abnormal_muscle_electrophysio | 1.69776489 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.68595941 |
| 40 | MP0001764_abnormal_homeostasis | 1.66271314 |
| 41 | MP0001853_heart_inflammation | 1.60999683 |
| 42 | MP0003436_decreased_susceptibility_to | 1.58765398 |
| 43 | MP0000685_abnormal_immune_system | 1.58308017 |
| 44 | MP0000681_abnormal_thyroid_gland | 1.58284298 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.57211259 |
| 46 | MP0003890_abnormal_embryonic-extraembry | 1.56131536 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.53643060 |
| 48 | MP0002163_abnormal_gland_morphology | 1.53142422 |
| 49 | MP0005310_abnormal_salivary_gland | 1.50147862 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.49527255 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.48693114 |
| 52 | MP0008789_abnormal_olfactory_epithelium | 1.46162718 |
| 53 | MP0003763_abnormal_thymus_physiology | 1.43661182 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.43374777 |
| 55 | MP0008260_abnormal_autophagy | 1.41505158 |
| 56 | MP0002796_impaired_skin_barrier | 1.40629334 |
| 57 | MP0003195_calcinosis | 1.39195299 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.39043310 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.38782538 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.38472469 |
| 61 | MP0005025_abnormal_response_to | 1.37626803 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.35636843 |
| 63 | MP0005451_abnormal_body_composition | 1.35196767 |
| 64 | MP0003786_premature_aging | 1.34053991 |
| 65 | MP0001542_abnormal_bone_strength | 1.33813558 |
| 66 | MP0001819_abnormal_immune_cell | 1.32839302 |
| 67 | MP0002398_abnormal_bone_marrow | 1.32498911 |
| 68 | MP0005387_immune_system_phenotype | 1.30901840 |
| 69 | MP0001790_abnormal_immune_system | 1.30901840 |
| 70 | MP0001915_intracranial_hemorrhage | 1.28128758 |
| 71 | MP0002102_abnormal_ear_morphology | 1.28019512 |
| 72 | MP0009333_abnormal_splenocyte_physiolog | 1.27608019 |
| 73 | MP0002723_abnormal_immune_serum | 1.24909360 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.24812840 |
| 75 | MP0003943_abnormal_hepatobiliary_system | 1.24329389 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.19688608 |
| 77 | MP0002006_tumorigenesis | 1.17426817 |
| 78 | MP0002166_altered_tumor_susceptibility | 1.17022822 |
| 79 | MP0001188_hyperpigmentation | 1.16283973 |
| 80 | MP0009764_decreased_sensitivity_to | 1.15065004 |
| 81 | MP0000716_abnormal_immune_system | 1.13646480 |
| 82 | MP0004233_abnormal_muscle_weight | 1.13419676 |
| 83 | MP0001800_abnormal_humoral_immune | 1.13247104 |
| 84 | MP0002139_abnormal_hepatobiliary_system | 1.12535824 |
| 85 | MP0005385_cardiovascular_system_phenoty | 1.11925491 |
| 86 | MP0009672_abnormal_birth_weight | 1.11515179 |
| 87 | MP0005266_abnormal_metabolism | 1.10303782 |
| 88 | MP0010307_abnormal_tumor_latency | 1.09602141 |
| 89 | MP0002429_abnormal_blood_cell | 1.08815231 |
| 90 | MP0000689_abnormal_spleen_morphology | 1.08032038 |
| 91 | MP0001756_abnormal_urination | 1.06147750 |
| 92 | MP0000313_abnormal_cell_death | 1.05941645 |
| 93 | MP0001672_abnormal_embryogenesis/_devel | 1.05668947 |
| 94 | MP0005380_embryogenesis_phenotype | 1.05668947 |
| 95 | MP0002332_abnormal_exercise_endurance | 1.04654011 |
| 96 | MP0004484_altered_response_of | 1.03771185 |
| 97 | MP0008877_abnormal_DNA_methylation | 1.03569606 |
| 98 | MP0004036_abnormal_muscle_relaxation | 1.03568065 |
| 99 | MP0002106_abnormal_muscle_physiology | 1.03235127 |
| 100 | MP0001697_abnormal_embryo_size | 1.02806832 |
| 101 | MP0002090_abnormal_vision | 1.00674209 |
| 102 | MP0002972_abnormal_cardiac_muscle | 0.98186629 |
| 103 | MP0008469_abnormal_protein_level | 0.97912395 |
| 104 | MP0005501_abnormal_skin_physiology | 0.94917990 |
| 105 | MP0002396_abnormal_hematopoietic_system | 0.94767703 |
| 106 | MP0004883_abnormal_blood_vessel | 0.94762513 |
| 107 | MP0006082_CNS_inflammation | 0.94340874 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.93782244 |
| 109 | MP0000465_gastrointestinal_hemorrhage | 0.93658526 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.93433120 |
| 111 | MP0004087_abnormal_muscle_fiber | 0.92673950 |
| 112 | MP0000747_muscle_weakness | 0.92595883 |
| 113 | MP0002269_muscular_atrophy | 0.92460837 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.91865812 |
| 115 | MP0005075_abnormal_melanosome_morpholog | 0.91398067 |
| 116 | MP0003984_embryonic_growth_retardation | 0.89636391 |
| 117 | MP0002722_abnormal_immune_system | 0.88523118 |
| 118 | MP0008995_early_reproductive_senescence | 0.88473976 |
| 119 | MP0002088_abnormal_embryonic_growth/wei | 0.88162891 |
| 120 | MP0001845_abnormal_inflammatory_respons | 0.87450537 |
| 121 | MP0000015_abnormal_ear_pigmentation | 0.86433422 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.86146306 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.85840208 |
| 124 | MP0000358_abnormal_cell_content/ | 0.85810667 |
| 125 | MP0002019_abnormal_tumor_incidence | 0.85140409 |
| 126 | MP0003123_paternal_imprinting | 0.84810480 |
| 127 | MP0004147_increased_porphyrin_level | 0.84525773 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.83608200 |
| 129 | MP0001177_atelectasis | 0.81376155 |
| 130 | MP0000490_abnormal_crypts_of | 0.81001270 |
| 131 | MP0002080_prenatal_lethality | 0.80797951 |
| 132 | MP0005248_abnormal_Harderian_gland | 0.80479220 |
| 133 | MP0000516_abnormal_urinary_system | 0.80211408 |
| 134 | MP0005367_renal/urinary_system_phenotyp | 0.80211408 |
| 135 | MP0004084_abnormal_cardiac_muscle | 0.80078662 |
| 136 | MP0005499_abnormal_olfactory_system | 0.79675565 |
| 137 | MP0005394_taste/olfaction_phenotype | 0.79675565 |
| 138 | MP0002736_abnormal_nociception_after | 0.79494701 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.77863756 |
| 140 | MP0003279_aneurysm | 0.77716883 |
| 141 | MP0001929_abnormal_gametogenesis | 0.76781870 |
| 142 | MP0002638_abnormal_pupillary_reflex | 0.76761536 |
| 143 | MP0010386_abnormal_urinary_bladder | 0.76350991 |
| 144 | MP0002971_abnormal_brown_adipose | 0.75956498 |
| 145 | MP0003950_abnormal_plasma_membrane | 0.75408110 |
| 146 | MP0000759_abnormal_skeletal_muscle | 0.73794380 |
| 147 | MP0002127_abnormal_cardiovascular_syste | 0.73731687 |
| 148 | MP0006292_abnormal_olfactory_placode | 0.73526905 |
| 149 | MP0009703_decreased_birth_body | 0.73044908 |
| 150 | MP0002735_abnormal_chemical_nociception | 0.70156747 |
| 151 | MP0005408_hypopigmentation | 0.68331903 |
| 152 | MP0002405_respiratory_system_inflammati | 0.68239798 |
| 153 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68208922 |
| 154 | MP0005376_homeostasis/metabolism_phenot | 0.67180091 |
| 155 | MP0004510_myositis | 0.66185979 |
| 156 | MP0000230_abnormal_systemic_arterial | 0.65866584 |
| 157 | MP0001968_abnormal_touch/_nociception | 0.65158501 |
| 158 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64397420 |
| 159 | MP0002160_abnormal_reproductive_system | 0.63590465 |
| 160 | MP0005535_abnormal_body_temperature | 0.63537511 |
| 161 | MP0001348_abnormal_lacrimal_gland | 0.61404609 |
| 162 | MP0001544_abnormal_cardiovascular_syste | 0.57865373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Disinhibition (HP:0000734) | 7.84765841 |
| 2 | Dyskinesia (HP:0100660) | 7.42950809 |
| 3 | Acute hepatic failure (HP:0006554) | 6.35380171 |
| 4 | Self-mutilation (HP:0000742) | 5.34841830 |
| 5 | Nemaline bodies (HP:0003798) | 5.27799593 |
| 6 | Inappropriate behavior (HP:0000719) | 5.13664352 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.98047946 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.88641228 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.82354859 |
| 10 | Personality changes (HP:0000751) | 4.64665616 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 4.43611748 |
| 12 | Poikilocytosis (HP:0004447) | 3.82803251 |
| 13 | Increased IgM level (HP:0003496) | 3.56042342 |
| 14 | Vasculitis (HP:0002633) | 3.50617251 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.37506122 |
| 16 | Drooling (HP:0002307) | 3.08966848 |
| 17 | Excessive salivation (HP:0003781) | 3.08966848 |
| 18 | Gonadotropin excess (HP:0000837) | 3.01608662 |
| 19 | Abnormality of T cell number (HP:0011839) | 3.00792343 |
| 20 | Choreoathetosis (HP:0001266) | 2.97732364 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 2.97047275 |
| 22 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.97047275 |
| 23 | Papillary thyroid carcinoma (HP:0002895) | 2.92747665 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 2.91308300 |
| 25 | Hypothermia (HP:0002045) | 2.88496867 |
| 26 | IgM deficiency (HP:0002850) | 2.78681111 |
| 27 | Irregular epiphyses (HP:0010582) | 2.78105551 |
| 28 | Posterior subcapsular cataract (HP:0007787) | 2.77813053 |
| 29 | Abnormality of T cell physiology (HP:0011840) | 2.77429484 |
| 30 | Abnormality of the anterior horn cell (HP:0006802) | 2.75533640 |
| 31 | Degeneration of anterior horn cells (HP:0002398) | 2.75533640 |
| 32 | Abnormal hair whorl (HP:0010721) | 2.75350513 |
| 33 | Rimmed vacuoles (HP:0003805) | 2.72949281 |
| 34 | Homocystinuria (HP:0002156) | 2.70810113 |
| 35 | Abnormality of homocysteine metabolism (HP:0010919) | 2.70810113 |
| 36 | Thyroid carcinoma (HP:0002890) | 2.67974065 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 2.61715228 |
| 38 | Recurrent abscess formation (HP:0002722) | 2.59025101 |
| 39 | Subaortic stenosis (HP:0001682) | 2.58905521 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.58905521 |
| 41 | Cutaneous melanoma (HP:0012056) | 2.58684591 |
| 42 | Insidious onset (HP:0003587) | 2.56013387 |
| 43 | Termporal pattern (HP:0011008) | 2.56013387 |
| 44 | Metaphyseal dysplasia (HP:0100255) | 2.50924562 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.50142835 |
| 46 | Anxiety (HP:0000739) | 2.49319271 |
| 47 | Exercise-induced myalgia (HP:0003738) | 2.48828298 |
| 48 | Recurrent bacterial skin infections (HP:0005406) | 2.48477576 |
| 49 | Recurrent fungal infections (HP:0002841) | 2.47185816 |
| 50 | Increased hepatocellular lipid droplets (HP:0006565) | 2.46823675 |
| 51 | Abnormality of glycolysis (HP:0004366) | 2.46713066 |
| 52 | Abnormality of the basal ganglia (HP:0002134) | 2.44591203 |
| 53 | T lymphocytopenia (HP:0005403) | 2.42823928 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.39272573 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.38811271 |
| 56 | Abnormal lung lobation (HP:0002101) | 2.36644457 |
| 57 | Rhabdomyolysis (HP:0003201) | 2.33854241 |
| 58 | Abnormal auditory evoked potentials (HP:0006958) | 2.33818121 |
| 59 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.31148405 |
| 60 | Methylmalonic acidemia (HP:0002912) | 2.30365326 |
| 61 | Birth length less than 3rd percentile (HP:0003561) | 2.28929703 |
| 62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28707835 |
| 63 | Tetraparesis (HP:0002273) | 2.27768058 |
| 64 | Embryonal renal neoplasm (HP:0011794) | 2.27089861 |
| 65 | Abnormality of salivation (HP:0100755) | 2.26788562 |
| 66 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.25839374 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.25548194 |
| 68 | Cholecystitis (HP:0001082) | 2.25548194 |
| 69 | Recurrent skin infections (HP:0001581) | 2.24247710 |
| 70 | Osteomalacia (HP:0002749) | 2.23444882 |
| 71 | Myoglobinuria (HP:0002913) | 2.22851043 |
| 72 | Pallor (HP:0000980) | 2.21393078 |
| 73 | Shoulder girdle muscle weakness (HP:0003547) | 2.19103475 |
| 74 | EMG: myopathic abnormalities (HP:0003458) | 2.19014279 |
| 75 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.16952557 |
| 76 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.16952557 |
| 77 | Neutropenia (HP:0001875) | 2.11589810 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.09591243 |
| 79 | Neck muscle weakness (HP:0000467) | 2.09331578 |
| 80 | Recurrent viral infections (HP:0004429) | 2.09275719 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.06960497 |
| 82 | Sensory axonal neuropathy (HP:0003390) | 2.06923157 |
| 83 | Amniotic constriction ring (HP:0009775) | 2.06870165 |
| 84 | Abnormality of placental membranes (HP:0011409) | 2.06870165 |
| 85 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06443930 |
| 86 | Calf muscle hypertrophy (HP:0008981) | 2.05855761 |
| 87 | Abnormality of T cells (HP:0002843) | 2.04472471 |
| 88 | Beaking of vertebral bodies (HP:0004568) | 2.04103682 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.03916455 |
| 90 | Nausea (HP:0002018) | 2.03663727 |
| 91 | IgG deficiency (HP:0004315) | 2.03552961 |
| 92 | Hypoglycemic coma (HP:0001325) | 2.02431803 |
| 93 | Exertional dyspnea (HP:0002875) | 2.02173634 |
| 94 | Microglossia (HP:0000171) | 2.00879963 |
| 95 | Acanthocytosis (HP:0001927) | 10.4882554 |
| 96 | Spinal canal stenosis (HP:0003416) | 1.99984469 |
| 97 | Psychosis (HP:0000709) | 1.98123847 |
| 98 | Aplastic anemia (HP:0001915) | 1.96597200 |
| 99 | Stomatitis (HP:0010280) | 1.95569320 |
| 100 | Carpal bone hypoplasia (HP:0001498) | 1.95382180 |
| 101 | Paralysis (HP:0003470) | 1.95165124 |
| 102 | Postnatal microcephaly (HP:0005484) | 1.95158730 |
| 103 | Pelvic girdle muscle weakness (HP:0003749) | 1.93009703 |
| 104 | Dyschromatopsia (HP:0007641) | 1.92408881 |
| 105 | Metaphyseal irregularity (HP:0003025) | 1.91606442 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 1.91527382 |
| 107 | Secondary amenorrhea (HP:0000869) | 1.91047252 |
| 108 | Cholelithiasis (HP:0001081) | 1.90524356 |
| 109 | Cortical dysplasia (HP:0002539) | 1.89519059 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 1.89458951 |
| 111 | Short tibia (HP:0005736) | 1.89427717 |
| 112 | Neoplasm of the adrenal gland (HP:0100631) | 1.89144290 |
| 113 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88740767 |
| 114 | Tongue fasciculations (HP:0001308) | 1.87282561 |
| 115 | Barrel-shaped chest (HP:0001552) | 1.87193072 |
| 116 | Symptomatic seizures (HP:0011145) | 1.87068148 |
| 117 | Short middle phalanx of the 5th finger (HP:0004220) | 1.83644738 |
| 118 | Autoamputation (HP:0001218) | 1.83364174 |
| 119 | Fatigue (HP:0012378) | 1.82851451 |
| 120 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.82526071 |
| 121 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.82526071 |
| 122 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81375182 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.80369192 |
| 124 | Deep philtrum (HP:0002002) | 1.79698100 |
| 125 | Areflexia of lower limbs (HP:0002522) | 1.78543197 |
| 126 | Abnormality of the columella (HP:0009929) | 1.77524880 |
| 127 | Renal Fanconi syndrome (HP:0001994) | 1.77467711 |
| 128 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77243054 |
| 129 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.77057142 |
| 130 | Hepatic necrosis (HP:0002605) | 1.76314039 |
| 131 | Muscle stiffness (HP:0003552) | 1.76140593 |
| 132 | Abnormality of the labia minora (HP:0012880) | 1.76077229 |
| 133 | Distal arthrogryposis (HP:0005684) | 1.76040546 |
| 134 | Mucosal telangiectasiae (HP:0100579) | 1.75941847 |
| 135 | Enlarged epiphyses (HP:0010580) | 1.75706017 |
| 136 | Biliary tract neoplasm (HP:0100574) | 1.75129086 |
| 137 | Abnormality of the septum pellucidum (HP:0007375) | 1.75005007 |
| 138 | Dysautonomia (HP:0002459) | 1.74921295 |
| 139 | Palpitations (HP:0001962) | 1.74102216 |
| 140 | Alveolar cell carcinoma (HP:0006519) | 1.73409013 |
| 141 | Abnormality of incisor morphology (HP:0011063) | 1.73135688 |
| 142 | Spontaneous abortion (HP:0005268) | 1.72803429 |
| 143 | Hepatocellular necrosis (HP:0001404) | 1.71527372 |
| 144 | Ovarian neoplasm (HP:0100615) | 1.70910475 |
| 145 | Difficulty running (HP:0009046) | 1.70906514 |
| 146 | Supernumerary spleens (HP:0009799) | 1.70536451 |
| 147 | Petechiae (HP:0000967) | 1.69497611 |
| 148 | Obstructive lung disease (HP:0006536) | 1.68797960 |
| 149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.68797960 |
| 150 | Median cleft lip (HP:0000161) | 1.68141699 |
| 151 | Methylmalonic aciduria (HP:0012120) | 1.67597405 |
| 152 | Abnormality of chromosome stability (HP:0003220) | 1.65191382 |
| 153 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.65127848 |
| 154 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.65127848 |
| 155 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.65085459 |
| 156 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.64220887 |
| 157 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.62890107 |
| 158 | Respiratory difficulties (HP:0002880) | 1.62436666 |
| 159 | Autoimmune hemolytic anemia (HP:0001890) | 1.62214871 |
| 160 | 3-Methylglutaconic aciduria (HP:0003535) | 1.62154713 |
| 161 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.61910185 |
| 162 | Meningitis (HP:0001287) | 1.60445747 |
| 163 | Volvulus (HP:0002580) | 1.60297307 |
| 164 | Menstrual irregularities (HP:0000858) | 1.60226346 |
| 165 | Proximal tubulopathy (HP:0000114) | 1.59986066 |
| 166 | Memory impairment (HP:0002354) | 1.59753765 |
| 167 | Type 1 muscle fiber predominance (HP:0003803) | 1.59369340 |
| 168 | Hypoplastic left heart (HP:0004383) | 1.58587633 |
| 169 | Conjunctival hamartoma (HP:0100780) | 1.58193926 |
| 170 | Chromsome breakage (HP:0040012) | 1.57397749 |
| 171 | Abnormality of the femoral head (HP:0003368) | 1.56729227 |
| 172 | Hypoplasia of the fovea (HP:0007750) | 1.55780695 |
| 173 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.55780695 |
| 174 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.55209201 |
| 175 | Hypergammaglobulinemia (HP:0010702) | 1.55037736 |
| 176 | Mitochondrial inheritance (HP:0001427) | 1.54351818 |
| 177 | Thrombocytosis (HP:0001894) | 1.53377089 |
| 178 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.53344871 |
| 179 | Microvesicular hepatic steatosis (HP:0001414) | 1.53131739 |
| 180 | Muscle fibrillation (HP:0010546) | 1.51394603 |
| 181 | Joint hemorrhage (HP:0005261) | 1.51093803 |
| 182 | Long clavicles (HP:0000890) | 1.50707880 |
| 183 | Syringomyelia (HP:0003396) | 1.50391890 |
| 184 | Spinal cord lesions (HP:0100561) | 1.50391890 |
| 185 | Chronic otitis media (HP:0000389) | 1.49728117 |
| 186 | Flared iliac wings (HP:0002869) | 1.49586072 |
| 187 | Fair hair (HP:0002286) | 1.48659828 |
| 188 | Generalized aminoaciduria (HP:0002909) | 1.48469913 |
| 189 | Joint swelling (HP:0001386) | 1.46697962 |
| 190 | Glucose intolerance (HP:0000833) | 1.45212574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 4.46376208 |
| 2 | BCR | 4.01197497 |
| 3 | EIF2AK1 | 3.97387108 |
| 4 | CASK | 3.27595217 |
| 5 | TRIM28 | 2.97961679 |
| 6 | MST4 | 2.97739974 |
| 7 | MKNK1 | 2.90749321 |
| 8 | OBSCN | 2.62169801 |
| 9 | BRSK2 | 2.35574959 |
| 10 | TXK | 2.33036993 |
| 11 | STK3 | 2.27231035 |
| 12 | MAP3K14 | 2.26942900 |
| 13 | BMPR2 | 2.26868783 |
| 14 | NEK1 | 2.21678016 |
| 15 | NEK9 | 2.20427544 |
| 16 | ERBB3 | 2.13378609 |
| 17 | ZAK | 2.06496366 |
| 18 | MKNK2 | 2.05729204 |
| 19 | NEK6 | 1.99319247 |
| 20 | PIK3CA | 1.90736630 |
| 21 | RPS6KA4 | 1.90160814 |
| 22 | PBK | 1.89986650 |
| 23 | MAP3K12 | 1.81888058 |
| 24 | FRK | 1.79809161 |
| 25 | CDK8 | 1.79331335 |
| 26 | TAF1 | 1.76268134 |
| 27 | AKT3 | 1.60759527 |
| 28 | NUAK1 | 1.57941463 |
| 29 | STK16 | 1.54698261 |
| 30 | MAP3K9 | 1.54246530 |
| 31 | ADRBK2 | 1.54162271 |
| 32 | TTK | 1.53380499 |
| 33 | LATS1 | 1.49891364 |
| 34 | BRD4 | 1.49132023 |
| 35 | SCYL2 | 1.48800707 |
| 36 | JAK3 | 1.44318029 |
| 37 | GRK7 | 1.37174088 |
| 38 | MAP4K1 | 1.34078793 |
| 39 | PLK4 | 1.32785023 |
| 40 | EIF2AK3 | 1.26655284 |
| 41 | DYRK3 | 1.24637107 |
| 42 | MYLK | 1.24531931 |
| 43 | INSRR | 1.19088551 |
| 44 | BUB1 | 1.17204905 |
| 45 | TSSK6 | 1.14301816 |
| 46 | YES1 | 1.12785569 |
| 47 | CDK6 | 1.10932550 |
| 48 | TIE1 | 1.08854570 |
| 49 | CDC42BPA | 1.08384904 |
| 50 | STK4 | 1.07770663 |
| 51 | WEE1 | 1.07463106 |
| 52 | PRPF4B | 1.07368362 |
| 53 | TNK2 | 1.02340464 |
| 54 | CDC7 | 1.00025239 |
| 55 | IKBKB | 0.97555228 |
| 56 | VRK1 | 0.97357817 |
| 57 | PLK2 | 0.93174113 |
| 58 | CHUK | 0.92931826 |
| 59 | TEC | 0.89063308 |
| 60 | BRSK1 | 0.88902060 |
| 61 | PASK | 0.88814554 |
| 62 | STK39 | 0.88804860 |
| 63 | STK10 | 0.88614997 |
| 64 | CDK3 | 0.87699365 |
| 65 | EIF2AK2 | 0.85234447 |
| 66 | GRK5 | 0.85086527 |
| 67 | STK24 | 0.83951246 |
| 68 | TGFBR2 | 0.82797624 |
| 69 | MUSK | 0.81609193 |
| 70 | MAP2K7 | 0.80981021 |
| 71 | PLK3 | 0.80865648 |
| 72 | NLK | 0.77979720 |
| 73 | SGK2 | 0.76435048 |
| 74 | KSR2 | 0.76316982 |
| 75 | CCNB1 | 0.76007659 |
| 76 | PINK1 | 0.75709492 |
| 77 | CDK19 | 0.72851975 |
| 78 | SRPK1 | 0.72559126 |
| 79 | IRAK2 | 0.68803814 |
| 80 | CLK1 | 0.67842166 |
| 81 | KSR1 | 0.66265362 |
| 82 | NME2 | 0.66246738 |
| 83 | RIPK4 | 0.65361739 |
| 84 | MAP3K5 | 0.59536813 |
| 85 | TBK1 | 0.58866978 |
| 86 | TAOK2 | 0.58763109 |
| 87 | SYK | 0.57218020 |
| 88 | PRKCD | 0.54977751 |
| 89 | PDK2 | 0.54685595 |
| 90 | MINK1 | 0.54600935 |
| 91 | TRPM7 | 0.53209549 |
| 92 | IRAK4 | 0.52746974 |
| 93 | CAMKK2 | 0.52741357 |
| 94 | PIK3CG | 0.52593844 |
| 95 | RAF1 | 0.52093028 |
| 96 | STK38L | 0.51661413 |
| 97 | PHKG2 | 0.51438323 |
| 98 | PHKG1 | 0.51438323 |
| 99 | MAP3K2 | 0.50830609 |
| 100 | MAP4K2 | 0.50762855 |
| 101 | MAP2K3 | 0.50404482 |
| 102 | PRKG2 | 0.49852852 |
| 103 | ZAP70 | 0.49773311 |
| 104 | IKBKE | 0.49608937 |
| 105 | BMPR1B | 0.47556374 |
| 106 | EGFR | 0.44127419 |
| 107 | CDK9 | 0.43899694 |
| 108 | BRAF | 0.43424194 |
| 109 | CDK4 | 0.43130473 |
| 110 | CSNK2A1 | 0.42408684 |
| 111 | DAPK1 | 0.41770002 |
| 112 | TNIK | 0.40813650 |
| 113 | BTK | 0.40332300 |
| 114 | CDK14 | 0.39962914 |
| 115 | CDK7 | 0.39858376 |
| 116 | OXSR1 | 0.39059207 |
| 117 | MAP3K8 | 0.38685302 |
| 118 | MAPKAPK2 | 0.38282880 |
| 119 | CHEK1 | 0.37240060 |
| 120 | PRKCE | 0.36532440 |
| 121 | PTK2B | 0.35971402 |
| 122 | DYRK1B | 0.34882667 |
| 123 | MAPKAPK5 | 0.34306821 |
| 124 | RPS6KA6 | 0.33363705 |
| 125 | LYN | 0.32575418 |
| 126 | ALK | 0.32201502 |
| 127 | ATM | 0.32129184 |
| 128 | ILK | 0.31586486 |
| 129 | PLK1 | 0.31586441 |
| 130 | JAK2 | 0.31094926 |
| 131 | CSNK1G3 | 0.31016458 |
| 132 | SGK3 | 0.29936774 |
| 133 | LCK | 0.29477524 |
| 134 | AURKB | 0.29441723 |
| 135 | CSNK2A2 | 0.28816514 |
| 136 | MOS | 0.28663995 |
| 137 | ACVR1B | 0.28625620 |
| 138 | LIMK1 | 0.28457932 |
| 139 | PIM2 | 0.28122907 |
| 140 | CSK | 0.27156768 |
| 141 | MARK3 | 0.26095707 |
| 142 | RPS6KC1 | 0.25988609 |
| 143 | RPS6KL1 | 0.25988609 |
| 144 | CSNK1G1 | 0.25374382 |
| 145 | FLT3 | 0.24844286 |
| 146 | LRRK2 | 0.23963550 |
| 147 | PRKG1 | 0.23913738 |
| 148 | IRAK1 | 0.23476489 |
| 149 | TESK1 | 0.23108014 |
| 150 | PIM1 | 0.22592691 |
| 151 | MAPK7 | 0.22394940 |
| 152 | CSF1R | 0.21978855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.05037578 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.61435167 |
| 3 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 3.37139430 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.06974375 |
| 5 | RNA degradation_Homo sapiens_hsa03018 | 2.75362759 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.74916382 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.34684937 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.28497439 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.27705915 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.27165985 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.19238136 |
| 12 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.10055123 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.01211940 |
| 14 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.95653031 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.90913894 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88391773 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.87571260 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86223441 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.73386187 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.70329671 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.69039005 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.68235020 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62182155 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60912572 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57499244 |
| 26 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.53533468 |
| 27 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.51182053 |
| 28 | Purine metabolism_Homo sapiens_hsa00230 | 1.50572111 |
| 29 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.45669675 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.33596053 |
| 31 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.33270764 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33109935 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32110364 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.31577502 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.26751172 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24178392 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.23941657 |
| 38 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21491016 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21065226 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17815611 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15946055 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15194568 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14190344 |
| 44 | Spliceosome_Homo sapiens_hsa03040 | 1.13943788 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13843678 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12772468 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10962940 |
| 48 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.08757834 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08582309 |
| 50 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08193143 |
| 51 | DNA replication_Homo sapiens_hsa03030 | 1.08172024 |
| 52 | Ribosome_Homo sapiens_hsa03010 | 1.04437221 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 1.04368466 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.02958336 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.02858635 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98041861 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97079515 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.96677378 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.94937062 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94001329 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92395591 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91961124 |
| 63 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91144438 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90517925 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.88674315 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87064482 |
| 67 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.86958191 |
| 68 | RNA transport_Homo sapiens_hsa03013 | 0.86908522 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86167041 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.84938984 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84484729 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82138107 |
| 73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.80169148 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.79633373 |
| 75 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79549569 |
| 76 | Malaria_Homo sapiens_hsa05144 | 0.76244129 |
| 77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75734308 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75458275 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.75033123 |
| 80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74407514 |
| 81 | Pertussis_Homo sapiens_hsa05133 | 0.73330807 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72907601 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71757819 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71131654 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71128445 |
| 86 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70870601 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69962110 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69386068 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69071255 |
| 90 | Tuberculosis_Homo sapiens_hsa05152 | 0.68422647 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.68239904 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66489952 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66086310 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65251935 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64931094 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63012435 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60808682 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60493514 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58632849 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53504704 |
| 101 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52243951 |
| 102 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52155813 |
| 103 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51458050 |
| 104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50242388 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49562774 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48075078 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47626235 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.46855485 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44884934 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44112118 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.42181455 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.41994370 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41931664 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40066584 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38132212 |
| 116 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38096755 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37923353 |
| 118 | Mismatch repair_Homo sapiens_hsa03430 | 0.37779489 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37376481 |
| 120 | Lysosome_Homo sapiens_hsa04142 | 0.36785373 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36679271 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.36467102 |
| 123 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35898856 |
| 124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35067448 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34869718 |
| 126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34540065 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.34143414 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.34099982 |
| 129 | Homologous recombination_Homo sapiens_hsa03440 | 0.33979215 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33886054 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.33472695 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.33430441 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31765995 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30136609 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29958793 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.29827385 |
| 137 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29407579 |
| 138 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29281773 |
| 139 | Shigellosis_Homo sapiens_hsa05131 | 0.28270982 |
| 140 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28096463 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27914644 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26423871 |

